Surmodics (SRDX)
(Delayed Data from NSDQ)
$32.37 USD
+0.15 (0.47%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $32.37 0.00 (0.00%) 5:26 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Surmodics, Inc. has a PEG ratio of 19.67 compared to the Medical - Products industry's PEG ratio of 1.85.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
SRDX 32.37 +0.15(0.47%)
Will SRDX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SRDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SRDX
SRDX Stock Up Following Q3 Earnings Beat, Gross Margin Contracts
SurModics (SRDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
SRDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
SurModics (SRDX) Q3 Earnings and Revenues Beat Estimates
ICU Medical (ICUI) Surpasses Q2 Earnings and Revenue Estimates
Evolus, Inc. (EOLS) Reports Q2 Loss, Lags Revenue Estimates
Other News for SRDX
Technical picture remains unchanged for SRDX after it rises 0.99% on September 18
Technical picture remains unchanged for SRDX after it falls 0.05% on September 17
SRDX's price falls by 1.39% on September 16, though its technical setup remains stable.
The technical outlook for SRDX is unchanged after it rises 1.28% on September 15
Technical picture remains unchanged for SRDX after it falls 0.96% on September 12